| Autor: |
Paz Rios, Luis H., Minga, Iva, Gaznabi, Safwan, Erwin, John, Tafur, Alfonso, Metzl, Mark D. |
| Zdroj: |
Journal of Interventional Cardiac Electrophysiology; Apr2023, Vol. 66 Issue 3, p525-529, 5p |
| Abstrakt: |
Cardiovascular implantable electronic device (CIED) therapy has become a safe and effective strategy for patients with symptomatic bradyarrhythmia and heart failure with reduced ejection fraction worldwide. Patients with CIED pocket infections often present with symptoms related to local inflammation but CIED endocarditis without the presence of a pocket infection can be more indolent and challenging to diagnose. Prior to the implementation of the EMA, physicians in the Cardiovascular Division were notified about hospitalized patients with CIED and bacteremia once device infection was suspected or already confirmed with imaging. There were 15 (6%) CIED extractions that subsequently occurred once device infection was identified, and 5 (2%) EMA were triggered for patients that had their CIED previously removed. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink